Novorapid Flextouch (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Flextouch, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It controls blood glucose in people with diabetes mellitus. GNH USA supplies Novorapid Flextouch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorapid Flextouch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorapid Flextouch is a rapid‑acting insulin analog that lowers blood glucose by acting on the insulin pathway.

- Type 1 diabetes mellitus: Improves post‑prandial glucose control. - Type 2 diabetes mellitus: Provides mealtime insulin coverage. - Gestational diabetes mellitus: Helps manage post‑meal glucose excursions. - Pre‑operative fasting: Reduces glucose levels before surgery. - Diabetic ketoacidosis treatment in hospital settings : St  

The